Despite the known role of VEGF in neovascularization (Folk and Stone, 2010), it has been shown that VEGF treatment reduces apoptosis in models of glaucoma whereas anti-VEGF therapies exacerbate neuronal cell death (Boia et al., 2020). The gene discussed is VEGFA; the disease is glaucoma.